Roche Holding Reports Non-GAAP EPS and Revenue for First Half
Roche Holding reported a first-half non-GAAP earnings per share (EPS) of CHF 10.85, with revenue totaling CHF 30.36 billion, representing a year-over-year decline of 1.9%. The Pharmaceuticals Division saw sales increase by 6% at constant exchange rates.
Topics: non-gaap_eps pharmaceuticals revenue